HomeNOX • ASX
add
Noxopharm Ltd
Previous close
$0.062
Day range
$0.060 - $0.062
Year range
$0.033 - $0.17
Market cap
18.12M AUD
Avg Volume
148.95K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 605.98K | -63.78% |
Operating expense | 1.01M | -36.30% |
Net income | -1.25M | 53.97% |
Net profit margin | -206.11 | -27.07% |
Earnings per share | — | — |
EBITDA | -1.13M | 58.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.16M | -53.61% |
Total assets | 7.16M | -67.35% |
Total liabilities | 580.77K | -81.93% |
Total equity | 6.58M | — |
Shares outstanding | 292.24M | — |
Price to book | 3.10 | — |
Return on assets | -39.45% | — |
Return on capital | -42.94% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.25M | 53.97% |
Cash from operations | 1.07M | 179.08% |
Cash from investing | — | — |
Cash from financing | 0.00 | 100.00% |
Net change in cash | 1.07M | 175.10% |
Free cash flow | -713.69K | 57.69% |
About
Founded
2015
Headquarters
Website
Employees
1,000